CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 35.62

CSPC Innovation Pharmaceutical Co., Ltd. experienced significant volatility on October 24, 2025, with the stock declining by 7.69% and reaching an intraday low of CNY 35.62. This performance stands in stark contrast to the China Shanghai Composite, which saw a modest gain of 0.71% on the same day. Over the past week, CSPC's stock has dropped 17.47%, and its monthly performance reflects a substantial decline of 29.53%. Despite a year-to-date increase of 36.25%, the company's long-term growth metrics raise concerns. The net sales growth has averaged only 9.76% annually over the last five years, while operating profit has seen a drastic decline of 212.16%. The company has reported negative results for six consecutive quarters, with a net profit of CNY -3.33 million, reflecting a decrease of 102.43%. Additionally, the return on capital employed (ROCE) is at a low of -2.26%. CSPC's current market capitalization stands at CNY 62,266 million, and it operates within the FMCG sector, characterized by a high price-to-book ratio of 16.80.